Stem Cell Manufacturing Market Size, Share, and Trends 2025 to 2034

The stem cell manufacturing market is set for strong growth, fueled by rising chronic disease prevalence, advancements in bioprocessing technologies, and increasing adoption of regenerative medicine. Projected to reach over USD 41 billion by 2034 at a CAGR of 11.32%, this market is transforming healthcare through innovative therapies and global research investments.

Last Updated : July 2025  |  Report Code : 4815  |  Category : Healthcare  |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Stem Cell Manufacturing Market 

5.1. COVID-19 Landscape: Stem Cell Manufacturing Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Stem Cell Manufacturing Market, By Product

8.1. Stem Cell Manufacturing Market Revenue and Volume, by Product

8.1.1 Consumables

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Instruments

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Stem Cell Lines

8.1.3.1. Market Revenue and Volume Forecast

Chapter 9. Global Stem Cell Manufacturing Market, By Application

9.1. Stem Cell Manufacturing Market Revenue and Volume, by Application

9.1.1. Research Applications

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Clinical Application

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Cell & Tissue Banking Applications

9.1.3.1. Market Revenue and Volume Forecast

Chapter 10. Global Stem Cell Manufacturing Market, By End-user 

10.1. Stem Cell Manufacturing Market Revenue and Volume, by End-user

10.1.1. Pharmaceutical & Biotechnology Companies

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Academic Institutes, Research Laboratories & Contract Research Organizations

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Hospitals & Surgical Centers

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Cell & Tissue Banks

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Others

10.1.5.1. Market Revenue and Volume Forecast

Chapter 11. Global Stem Cell Manufacturing Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Product

11.1.2. Market Revenue and Volume Forecast, by Application

11.1.3. Market Revenue and Volume Forecast, by End-user

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Product

11.1.4.2. Market Revenue and Volume Forecast, by Application

11.1.4.3. Market Revenue and Volume Forecast, by End-user

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Product

11.1.5.2. Market Revenue and Volume Forecast, by Application

11.1.5.3. Market Revenue and Volume Forecast, by End-user

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Product

11.2.2. Market Revenue and Volume Forecast, by Application

11.2.3. Market Revenue and Volume Forecast, by End-user

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Product

11.2.4.2. Market Revenue and Volume Forecast, by Application

11.2.4.3. Market Revenue and Volume Forecast, by End-user

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Product

11.2.5.2. Market Revenue and Volume Forecast, by Application

11.2.5.3. Market Revenue and Volume Forecast, by End-user

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Product

11.2.6.2. Market Revenue and Volume Forecast, by Application

11.2.6.3. Market Revenue and Volume Forecast, by End-user

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Product

11.2.7.2. Market Revenue and Volume Forecast, by Application

11.2.7.3. Market Revenue and Volume Forecast, by End-user

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Product

11.3.2. Market Revenue and Volume Forecast, by Application

11.3.3. Market Revenue and Volume Forecast, by End-user

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Product

11.3.4.2. Market Revenue and Volume Forecast, by Application

11.3.4.3. Market Revenue and Volume Forecast, by End-user

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Product

11.3.5.2. Market Revenue and Volume Forecast, by Application

11.3.5.3. Market Revenue and Volume Forecast, by End-user

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Product

11.3.6.2. Market Revenue and Volume Forecast, by Application

11.3.6.3. Market Revenue and Volume Forecast, by End-user

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Product

11.3.7.2. Market Revenue and Volume Forecast, by Application

11.3.7.3. Market Revenue and Volume Forecast, by End-user

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Product

11.4.2. Market Revenue and Volume Forecast, by Application

11.4.3. Market Revenue and Volume Forecast, by End-user

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Product

11.4.4.2. Market Revenue and Volume Forecast, by Application

11.4.4.3. Market Revenue and Volume Forecast, by End-user

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Product

11.4.5.2. Market Revenue and Volume Forecast, by Application

11.4.5.3. Market Revenue and Volume Forecast, by End-user

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Product

11.4.6.2. Market Revenue and Volume Forecast, by Application

11.4.6.3. Market Revenue and Volume Forecast, by End-user

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Product

11.4.7.2. Market Revenue and Volume Forecast, by Application

11.4.7.3. Market Revenue and Volume Forecast, by End-user

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Product

11.5.2. Market Revenue and Volume Forecast, by Application

11.5.3. Market Revenue and Volume Forecast, by End-user

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Product

11.5.4.2. Market Revenue and Volume Forecast, by Application

11.5.4.3. Market Revenue and Volume Forecast, by End-user

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Product

11.5.5.2. Market Revenue and Volume Forecast, by Application

11.5.5.3. Market Revenue and Volume Forecast, by End-user

Chapter 12. Company Profiles

12.1. Thermo Fisher Scientific, Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Lonza Group

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Eppendorf AG

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Miltenyi Biotec GmBH

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Anterogen Co. Ltd.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. American Cryostem Corporation

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Pluristem Therapeutics Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Daiichi Sankyo

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Sartorius AG

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Danaher Corporation

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global stem cell manufacturing market size is expected to increase USD 41.45 billion by 2034 from USD 14.18 billion in 2024.

The stem cell manufacturing market is anticipated to grow at a CAGR of over 11.32% between 2025 and 2034.

The major players operating in the stem cell manufacturing market are Thermo Fisher Scientific, Inc., Lonza Group, Eppendorf AG, Miltenyi Biotec GmBH, Anterogen Co. Ltd., American Cryostem Corporation, Pluristem Therapeutics Inc., Daiichi Sankyo, Sartorius AG, Danaher Corporation, CellGenix GmBH, PromoCell, Organogenesis Holdings Inc., and others.

The driving factors of the stem cell manufacturing market are the growing stem cell banking industry and increasing awareness of and acceptance of regenerative medicine.

North America region will lead the global stem cell manufacturing market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client